Author

EMILY WELCH

Observed names: E. Welch, Emily Welch

ORCID: 0000-0002-1874-066X

Observed ORCID: 0000-0002-1874-066X

OpenAlex ID: A5109643134

Treatment Patterns and Health Care Resource Utilization Among Patients With Potentially Treatment-refractory Mycobacterium Avium Complex Lung Disease in the United States

2023 · KEVIN L WINTHROP, PING WANG, et al. · CHEST Journal · 3

Longer Use of Amikacin Liposome Inhalation Suspension During First 12 Months Associated With Lower Risk of Hospitalizations and Emergency Room Visits: a Claims Analysis

2024 · KEVIN L WINTHROP, CATHERINE WAWERU, et al. · CHEST Journal · 1

Impact of timing of nontuberculous mycobacterial pulmonary disease antibiotic initiation on hospitalizations in Japan

2026 · Catherine Waweru, Kozo Morimoto, et al. · Respiratory Investigation

Exacerbations among incident cases of bronchiectasis in Japan

2025 · Takanori Asakura, Ping Wang, et al. · European Respiratory Journal

Healthcare Resource Utilization Associated With Treatment for Refractory Mycobacterium Avium Complex Lung Disease: Comparison of Amikacin Liposome Inhalation Suspension (ALIS) vs Non-ALIS Antibiotic Treatment

2025 · T.R. Aksamit, C. Waweru, et al. · American Journal of Respiratory and Critical Care Medicine

Impact of Timing of Nontuberculous Mycobacterial Lung Disease Antibiotic Initiation on Hospitalizations and Outpatient Visits in Japan

2024 · CATHERINE WAWERU, KOZO MORIMOTO, et al. · CHEST Journal

Works count: 6

Citation count: 4

H-index: 1

I10-index: